Provided by Tiger Fintech (Singapore) Pte. Ltd.

Crescent Biopharma Inc

13.22
+0.32252.50%
Volume:21.97K
Turnover:287.97K
Market Cap:183.69M
PE:-0.29
High:13.28
Open:12.92
Low:12.90
Close:12.90
52wk High:63.00
52wk Low:10.83
Shares:13.89M
Float Shares:13.38M
Volume Ratio:1.06
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-45.7196
EPS(LYR):-58.7480
ROE:-182.66%
ROA:-73.99%
PB:2.53
PE(LYR):-0.23

Loading ...

Crescent Biopharma initiated with a Buy at H.C. Wainwright

TIPRANKS
·
Yesterday

Crescent Biopharma, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating and Target Price $25

THOMSON REUTERS
·
Yesterday

Crescent Biopharma Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 01

TD Cowen Remains a Buy on Crescent Biopharma (CBIO)

TIPRANKS
·
Aug 01

BRIEF-Crescent Biopharma Inc Q2 EPS $-4.93

Reuters
·
Jul 31

Crescent Biopharma Q2 EPS $(4.93) Misses $(1.11) Estimate, Cash Balance Of $152.6M

Benzinga
·
Jul 31

Crescent Biopharma Inc. Announces New Leadership Team to Drive Oncology Drug Development and Biotech Growth

Reuters
·
Jul 31

Crescent Biopharma Reports Q2 2025 Net Loss of $21.8M, EPS at $4.93 per Share

Reuters
·
Jul 31

Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights

THOMSON REUTERS
·
Jul 31

Crescent Biopharma Inc expected to post a loss of $1.76 a share - Earnings Preview

Reuters
·
Jul 30

Crescent Biopharma Inc. Files Initial Statement of Beneficial Ownership: Jan Pinkas, Chief Scientific Officer

Reuters
·
Jul 16

Crescent Biopharma Initiated at Outperform by Wedbush

Dow Jones
·
Jul 14

Wedbush Initiates Crescent Biopharma at Outperform With $27 Price Target

MT Newswires Live
·
Jul 14

BRIEF-Crescent Biopharma Appoints Jan Pinkas, Ph.D., As Chief Scientific Officer

Reuters
·
Jul 08

Crescent Biopharma appoints Jan Pinkas as CSO

TIPRANKS
·
Jul 08

Press Release: Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer

Dow Jones
·
Jul 08

Crescent Biopharma: A Promising Investment in the Growing PD-(L)1-Targeting Market

TIPRANKS
·
Jun 25

Crescent Biopharma initiated with a Buy at Stifel

TIPRANKS
·
Jun 25

Crescent Biopharma Inc. Files Initial Statement of Beneficial Ownership, Naming Susan Moran as Director

Reuters
·
Jun 24

TD Cowen Initiates Coverage on Crescent Biopharma With Buy Rating

MT Newswires Live
·
Jun 20